Improving Early Colostrum Administration to Very Low Birth Weight Infants in a Level 3 Neonatal Intensive Care Unit: A Quality Improvement Initiative - 08/09/23
, Corinne Morrison, PA 2, Allison Nascimento, RN 2, Debra Stone, RN, IBCLC 3, Eliza Myers, MD, IBCLC 1, 2Abstract |
Objective |
To improve our human milk practices by increasing early and sustained use of colostrum as oral immune therapy (OIT) in very low birthweight (VLBW) infants admitted at a level 3 neonatal intensive care unit.
Study design |
Using the Institute for Healthcare Improvement’s Model for Improvement, several interventions aimed at increasing early OIT administration were implemented. Four key drivers included: optimizing evidence-based OIT guidelines, personnel alignment and engagement, optimal electronic health record use for ordering practices, and timely lactation consultant involvement. The primary outcome measure was early OIT administration, whereas secondary outcome measures examined all OIT administration and human milk at discharge. Process measures included the percentage of staff members who were compliant with OIT protocol.
Results |
Early OIT administration increased from a baseline mean of 6% to 55% in the 12-month study period. Percentage of total (early and late) OIT administration to VLBW infants increased from a baseline of 21% to 85%. Average human milk at discharge for VLBW infants remained at 44%, without significant improvement.
Conclusions |
A multidisciplinary quality improvement initiative led to significant improvement in OIT administration to infants at a level 3 neonatal intensive care unit.
Le texte complet de cet article est disponible en PDF.Keywords : Immunotherapy, preterm, breastmilk, colostrum
Abbreviations : APP, EHR, NEC, NICU, OIT, PDSA, QI, VLBW
Plan
| The authors have no financial relationships relevant to this article to disclose. The authors have no conflicts of interest to disclose. |
Vol 260
Article 113421- septembre 2023 Retour au numéro
Article précédent
- Cardiac Magnetic Resonance Findings of Coronavirus Disease 2019 (COVID-19) Vaccine-Associated Myopericarditis at Intermediate Follow-Up: A Comparison with Classic Myocarditis
- Matthew L. Dove, Timothy C. Slesnick, Matthew E. Oster, Sassan Hashemi, Trisha Patel, Hunter C. Wilson
- Racial and Ethnic Disparities in Sudden Unexpected Infant Death Among US Infants Born Preterm
- Sunah S. Hwang, Stephanie L. Bourque, Kathleen E. Hannan, Molly Passarella, Joshua Radack, Brielle Formanowski, Scott A. Lorch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?